Coherus Management to Participate in the 2024 Citi Global Healthcare Conference
Coherus Management to Participate in the 2024 Citi Global Healthcare Conference
REDWOOD CITY, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. ("Coherus," NASDAQ: CHRS) today announced that senior management will participate in the 2024 Citi Global Healthcare Conference, with Dr. Theresa LaVallee, Chief Development Officer, sitting on the Novel Mechanisms in Oncology Panel on December 3, 2024, at 3:15 p.m. ET.
加利福尼亞州紅木城，2024年11月27日（全球新聞通訊）-- Coherus BioSciences, Inc.（"Coherus," 納斯達克: CHRS）今天宣佈，公司的高級管理層將參加2024年花旗全球醫療會議，首席發展官特蕾莎·拉瓦利博士將於2024年12月3日下午3:15參與腫瘤學新機制小組討論。
The panel discussion will be accessible via webcast through a link on the Investor Events and Presentations section of the Coherus website: .
小組討論將通過Coherus網站投資者活動和演示部分的鏈接進行網絡直播。
Coherus Contact Information:
For Investors:
Jodi Sievers
VP, Investor Relations & Corporate Communications
IR@coherus.com
Coherus聯繫信息:
對於投資者：
喬迪·西弗斯
VP，投資者關係和企業通訊
ir@coherus.com
譯文內容由第三人軟體翻譯。
